Kombiglyze XR Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Kombiglyze XR Tablet combines saxagliptin, a DPP-4 inhibitor, with extended-release metformin, a biguanide. It is prescribed to manage blood glucose in type 2 diabetes mellitus, lowering glucose production in the liver and its absorption, and is taken with meals to reduce stomach upset.

Active ingredients
Saxagliptin + Metformin hydrochloride (extended-release)
Dosage form
Extended-release oral tablet
Therapeutic class
DPP-4 inhibitor + biguanide
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with saxagliptin and metformin and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Management of blood glucose in type 2 diabetes mellitus, alongside diet and exercise
  • May be used with other antidiabetic medicines in the order directed by the prescriber
  • Described as helping to reduce diabetes-related complications such as kidney, eye, and nerve damage
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Swallowed whole with meals; not to be crushed, chewed, or broken
  • Taken at the dose and duration prescribed; the course should be completed
  • Taken with food to help avoid an upset stomach

Described Side Effects

Commonly described side effects include:

  • Nausea, vomiting, diarrhoea, or abdominal pain
  • Loss of appetite and indigestion
  • Headache and dizziness
  • Upper respiratory tract infection
  • Muscle pain; fatigue

Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • History of kidney, liver, heart, or pancreatic disease should be disclosed to the prescriber
  • Pregnancy or breastfeeding should be discussed with the prescriber
  • Heavy alcohol use should be reported, given the risk of lactic acidosis with metformin
  • Full medical history and current medicines should be shared with the prescriber

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling, it combines saxagliptin and extended-release metformin to manage blood glucose in type 2 diabetes mellitus. SDO Pharma has not independently verified these claims.

Swallowed whole with meals, without crushing or chewing, at the dose and duration set by the prescriber.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services